ML133 HCl

CAS No. 1222781-70-5

ML133 HCl ( —— )

Catalog No. M17888 CAS No. 1222781-70-5

ML133 HCl is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 μM (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 Get Quote
10MG 55 Get Quote
25MG 97 Get Quote
50MG 156 Get Quote
100MG 259 Get Quote
200MG 336 Get Quote
500MG 566 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ML133 HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    ML133 HCl is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 μM (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1.
  • Description
    ML133 HCl is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 μM (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    Kir2.1
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    1222781-70-5
  • Formula Weight
    313.82
  • Molecular Formula
    C19H19NO·HCl
  • Purity
    98%
  • Solubility
    DMSO : ≥ 125 mg/mL; 398.32 mM
  • SMILES
    Cl.COC1=CC=C(CNCC2=CC=CC3=C2C=CC=C3)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang HR, et al. ACS Chem Biol, 2011, 6(8), 845-856.
molnova catalog
related products
  • 2-Chloropyrazine

    2-Chloropyrazine is used in chemical industry.

  • PF-06873600

    PF-06873600 (PF06873600, PF 06873600) is a potent, orally bioavailable inhibitor of cyclin-dependent kinase (CDK) with Ki values of 0.09 nM, 0.13 nM and 0.16 nM for CDK2, CDK4 and CDK6, respectively.

  • LY3143921

    LY3143921 (LY-3143921) is an orally available, potent, selective inhibitor of Cdc7 kinase inhibitor, inhibits CDC7/DBF4 I and pMCM2 (S53) with IC50 values of 3.3 nM and 290 nM, respectively.